Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis
Targeting self-renewing cancer cells without deleterious side effects in normal tissues has proven challenging. Here, the authors show that the well-tolerated HDAC inhibitor Quisinostat safely inhibits tumor maintenance and disease relapse by restoring high levels of histone H1.0.
Bibliographic Details
| Main Authors: |
Cristina Morales Torres,
Mary Y. Wu,
Sebastijan Hobor,
Elanor N. Wainwright,
Matthew J. Martin,
Harshil Patel,
William Grey,
Eva Grönroos,
Steven Howell,
Joana Carvalho,
Ambrosius P. Snijders,
Michael Bustin,
Dominique Bonnet,
Paul D. Smith,
Charles Swanton,
Michael Howell,
Paola Scaffidi |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Nature Publishing Group
2020-04-01
|
|---|
| Series: | Nature Communications
|
|---|
| Online Access: | https://doi.org/10.1038/s41467-020-15615-z
|
|---|
